Introduction Cell-culture-based technology for vaccine production is robust, reliable, and could become a practical alternative for the pharmaceutical industry. Once the virus is propagated and harvested, the downstream processing parameters for purification, filling, and packaging of the vaccine ar.....
[更多]
Provides a renewable and scalable source of glial-enriched progenitors for therapeutics and research
[更多]
• Can improve the effectiveness of mTOR inhibitors, which have not been a successful monotherapy for glioblastoma.• Blocks Cyclin D1 and c-MYC IRES-mediated protein synthesis, which is a crucial resistance mechanism for mTOR inhibitor-treated cancer cells.
[更多]
